Pfizer/BioNTech vaccine approved for children by Swiss regulator
The Swiss medical regulator has approved the use of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to 11. However, the Federal Vaccination Commission has yet to recommend extending the immunisation campaign to this group.
This content was published on
2 minutes
swissinfo.ch/dos
Español
es
Suiza aprueba la vacuna de Pfizer/BioNTech para niños
“The clinical trial results show that the vaccine is safe and effective in this age group,” wrote Swissmedic on FridayExternal link. It said an ongoing study involving more than 1,500 people showed “almost complete protection against serious illness” caused by Covid-19 among those aged five to 11 and that side effects tended to occur less frequently than in adolescents or adults.
These side effects – slightly more frequent after the second dose – can include pain at the point of injection, tiredness, and occasionally headaches, joint pain, or fever.
The regulator recommends two doses of the vaccine, three weeks apart, but at just one-third the strength of a normal adult dose.
However, a recommendation by the Federal Vaccination Commission would be needed before the national immunisation strategy would be updated to include this age group, Swissmedic told the Keystone-SDA news agency.
As of Friday evening, the website of the Federal Office of Public Health indicated that “currently there are no plans to vaccinate children under 12”.
Moderna waiting
Meanwhile, Moderna’s Spikevax vaccine is still under review by Swissmedic for use on children, with no decision yet taken. The Janssen viral vector vaccine, the third being used on adults in Switzerland, has not been submitted for consideration on children.
Overall, despite efforts by authorities to spur interest, the Swiss are still among the most reluctant to vaccinate in Western Europe; as of Friday, some 68% of the population had received at least one vaccine dose, amounting to around 78% of the adult (aged 19 and above) population.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Switzerland to introduce flight passenger database
This content was published on
Switzerland plans to introduce a flight passenger database to collect and process personal data in a bid to combat terrorism and serious crime.
Government plans to invest over CHF16bn in Swiss rail network
This content was published on
The federal government intends to invest CHF16.4 billion ($18.1 billion) in railway infrastructure between 2025 and 2028, CHF2 billion more than for the current period.
Swiss to vote on pension reform and biodiversity in September
This content was published on
Swiss citizens will vote on occupational pension schemes and a biodiversity initiative on September 22, the Federal Council announced on Wednesday.
Ukraine peace talks: 50 countries have confirmed participation
This content was published on
To date, 50 countries out 160 invited delegations have confirmed they will attend the Ukraine peace conference, held in central Switzerland in mid-June, according to Swiss public radio, RTS.
Federer-backed On boosts forecast after sneaker demand rises
This content was published on
Swiss footwear company On Holding AG posted strong first-quarter revenue, boosted by demand for its running shoes and new line of training apparel.
Michael Schumacher’s watches fetch CHF4 million at Swiss auction
This content was published on
Watches belonging to Formula 1 great Michael Schumacher sold for around CHF4 million ($4.41 million) at auction house Christie's in Geneva on Tuesday.
Macron will attend Swiss summit on Ukraine, says Zelensky
This content was published on
French President Emmanuel Macron will attend the peace conference on Ukraine at the Swiss Bürgenstock resort next month, according to Volodymyr Zelensky.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Government moots more Covid measures, including partial closures
This content was published on
A week after tightening certificate and mask-wearing rules, the government has proposed new measures to ease Covid-19 pressure on hospitals.
Study shows benefit of regular classroom ventilation
This content was published on
A Swiss study has found that poorly ventilated school classrooms record up to six times as many Covid-19 cases compared with those which are regularly aired.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.